Table 3. Relationship between special staining results and clinical factors.
| Variable | Mast cell proliferation | Neural hyperplasia | Merkel cell hyperplasia | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Giemsa positive | p-value | Odds ratio | S-100 positive | p-value | NSE positive | p-value | CK-20 positive | p-value | CAM 5.2 positive | p-value | CK8 and CK18 positive | p-value | ||
| Atopic dermatitis (n=209) | 17 | 0.0280* | 0.0347* | 32 | 0.9088 | 57 | 0.6651 | 2 | 0.6377 | 37 | 0.9097 | 90 | 0.8323 | |
| Present (n=126) | 6 (35.3) | 19 (59.4) | 33 (57.9) | 1 (50.0) | 22 (59.5) | 55 (61.1) | ||||||||
| Not present (n=83) | 11 (64.7) | 13 (40.6) | 24 (42.1) | 1 (50.0) | 15 (40.5) | 35 (38.9) | ||||||||
| Treatment response (n=209) | 17 | 0.7742 | 32 | 0.1619 | 57 | 0.8565 | 2 | 0.1048 | 37 | 0.7099 | 90 | 0.4962 | ||
| Improved (n=68) | 5 (29.4) | 7 (21.9) | 18 (31.6) | 2 (100) | 13 (35.1) | 27 (30.0) | ||||||||
| Non improved (n=141) | 12 (70.6) | 25 (78.1) | 39 (68.4) | 0 (0) | 24 (64.9) | 63 (70.0 | ||||||||
| Treatment response (n=134) | 13 | 0.3512 | 19 | 0.1907 | 35 | 0.9252 | 2 | 0.4964 | 24 | 0.7114 | 58 | 0.3962 | ||
| Improved (n=68) | 5 (38.5) | 7 (36.8) | 18 (51.4) | 2 (100) | 13 (54.2) | 27 (46.6) | ||||||||
| Non improved (n=66) | 8 (61.5) | 12 (63.2) | 17 (48.6) | 0 (0) | 11 (45.8) | 31 (53.4) | ||||||||
Values are presented as number only or number (%). NSE: neuron-Specific Enolase, CK: cytokeratin. *Statistically significant (p<0.05).